Does price disclosure promote competition in private MRI markets? A difference-in-differences analysis

In Finland’s private health care markets, a lack of price transparency has made price shopping difficult for consumers in the past. To address this issue, two distinct online price comparison tools were introduced. Economic theory and empirical research suggest that increasing price transparency can lower prices, but the impact depends on market conditions and the design of price disclosure. This paper examines the effect of these two distinct price disclosures on the prices of private magnetic resonance imaging (MRI) in Finland. We utilize comprehensive administrative data from the National Health Insurance of Finland, which include all reimbursed procedures and prices in the private sector from 2008 to 2017. We employ a difference-in-differences approach to estimate the causal effects of price disclosures. Additionally, we use a market concentration index to control for the ex ante level of competition and explore whether market concentration is associated with the price effects. We found that only the second price disclosure reduced MRI prices, with provider prices lowering by 5.2% and market prices by 10.6% relative to those of the control group. The effects varied across regions and time: the provider price effect became statistically insignificant after a year, whereas market prices reached a statistically significant reduction of 12% until the end of the study period. The effect was also stronger for concentrated markets, suggesting that price transparency inhibits companies’ ability to exert monopoly power. The results align with those of previous studies, indicating that competition can be promoted through price transparency and that information disclosure is more effective when baseline market performance is low. As MRI services are highly standardized, it is unlikely that providers lower prices by compromising quality. However, a definitive conclusion on consumer welfare gains cannot be drawn. The different effects of the two price disclosures highlight the importance of design and market conditions in promoting competition and gaining savings. The first price disclosure failed, as it did not reveal the relevant price information sufficiently, and ex ante market conditions lowered the price sensitivity of both the consumers and providers.

Authors

Institutions

Publication Details

Journal
Health Economics Review
Published
2025-11-22
DOI
https://doi.org/10.1186/s13561-025-00691-y
Primary Topic
Healthcare Policy and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Does price disclosure promote competition in private MRI markets? A difference-in-differences analysis

Riina Hiltunen
Health Economics Review
Healthcare Policy and Management
article

Does price disclosure promote competition in private MRI markets? A difference-in-differences analysis

Riina Hiltunen
article en

Abstract

In Finland’s private health care markets, a lack of price transparency has made price shopping difficult for consumers in the past. To address this issue, two distinct online price comparison tools were introduced. Economic theory and empirical research suggest that increasing price transparency can lower prices, but the impact depends on market conditions and the design of price disclosure. This paper examines the effect of these two distinct price disclosures on the prices of private magnetic resonance imaging (MRI) in Finland. We utilize comprehensive administrative data from the National Health Insurance of Finland, which include all reimbursed procedures and prices in the private sector from 2008 to 2017. We employ a difference-in-differences approach to estimate the causal effects of price disclosures. Additionally, we use a market concentration index to control for the ex ante level of competition and explore whether market concentration is associated with the price effects. We found that only the second price disclosure reduced MRI prices, with provider prices lowering by 5.2% and market prices by 10.6% relative to those of the control group. The effects varied across regions and time: the provider price effect became statistically insignificant after a year, whereas market prices reached a statistically significant reduction of 12% until the end of the study period. The effect was also stronger for concentrated markets, suggesting that price transparency inhibits companies’ ability to exert monopoly power. The results align with those of previous studies, indicating that competition can be promoted through price transparency and that information disclosure is more effective when baseline market performance is low. As MRI services are highly standardized, it is unlikely that providers lower prices by compromising quality. However, a definitive conclusion on consumer welfare gains cannot be drawn. The different effects of the two price disclosures highlight the importance of design and market conditions in promoting competition and gaining savings. The first price disclosure failed, as it did not reveal the relevant price information sufficiently, and ex ante market conditions lowered the price sensitivity of both the consumers and providers.

Health Economics ReviewVol. 16(1)
Social Insurance Institution (FI)
Openalex Percentile: Top 56%
Healthcare Policy and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.